izpis_h1_title_alt

The structural features of novel bacterial topoisomerase inhibitors that define their activity on topoisomerase IV
ID Kokot, Maja (Author), ID Anderluh, Marko (Author), ID Hrast, Martina (Author), ID Minovski, Nikola (Author)

.pdfPDF - Presentation file, Download (5,07 MB)
MD5: E7BE7C5FBF565F032561CBA64E64B6A3
URLURL - Source URL, Visit https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c00039 This link opens in a new window

Abstract
The continued emergence of bacterial resistance has created an urgent need for new and effective antibacterial agents. Bacterial type II topoisomerases, such as DNA gyrase and topoisomerase IV (topoIV), are well-validated targets for antibacterial chemotherapy. The novel bacterial topoisomerase inhibitors (NBTIs) represent one of the new promising classes of antibacterial agents. They can inhibit both of these bacterial targets; however, their potencies differ on the targets among species, making topoIV probably a primary target of NBTIs in Gram-negative bacteria. Therefore, it is important to gain an insight into the NBTIs key structural features that govern the topoIV inhibition. However, in Gram-positive bacteria, topoIV is also a significant target for achieving dual-targeting, which in turn contributes to avoiding bacterial resistance caused by single-target mutations. In this perspective, we address the structure–activity relationship guidelines for NBTIs that target the topoIV enzyme in Gram-positive and Gram-negative bacteria.

Language:English
Keywords:genetics, inhibition, bacteria, phenyls
Work type:Article
Typology:1.02 - Review Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:Str. 6431–6440
Numbering:Vol. 65, iss. 9
PID:20.500.12556/RUL-140640 This link opens in a new window
UDC:615.4:54:615.015.8
ISSN on article:0022-2623
DOI:10.1021/acs.jmedchem.2c00039 This link opens in a new window
COBISS.SI-ID:106691587 This link opens in a new window
Publication date in RUL:16.09.2022
Views:415
Downloads:188
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of medicinal chemistry
Shortened title:J. med. chem.
Publisher:American Chemical Society
ISSN:0022-2623
COBISS.SI-ID:25763328 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:farmacevtska kemija, bakterijska rezistenca

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0017
Name:Modeliranje kemijskih procesov in lastnosti spojin

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARRS - Slovenian Research Agency
Funding programme:Young researchers

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back